Variant report
Variant | nsv573311 |
---|---|
Chromosome Location | chr16:80979086-80981548 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11150329 | chr16:80979086-80979087 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs377697611 | chr16:80979090-80979091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543083324 | chr16:80979143-80979144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75653738 | chr16:80979148-80979149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181441347 | chr16:80979164-80979165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184816856 | chr16:80979195-80979196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566008934 | chr16:80979196-80979197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529931735 | chr16:80979201-80979202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs8043968 | chr16:80979215-80979216 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs567637189 | chr16:80979231-80979232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188384683 | chr16:80979260-80979261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556654652 | chr16:80979261-80979262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571873784 | chr16:80979281-80979282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539266540 | chr16:80979332-80979333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149975242 | chr16:80979388-80979389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572731387 | chr16:80979424-80979425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs35496593 | chr16:80979433-80979434 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs9652681 | chr16:80979454-80979455 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs530649033 | chr16:80979471-80979472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34415128 | chr16:80979491-80979492 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539878315 | chr16:80979506-80979507 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553193113 | chr16:80979535-80979536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113772701 | chr16:80979557-80979558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550648433 | chr16:80979592-80979593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs74427385 | chr16:80979608-80979609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs180944725 | chr16:80979616-80979617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564688464 | chr16:80979617-80979618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532071209 | chr16:80979637-80979638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541256695 | chr16:80979641-80979642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185168134 | chr16:80979677-80979678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530025447 | chr16:80979680-80979681 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572871530 | chr16:80979711-80979712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548151925 | chr16:80979718-80979719 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34486948 | chr16:80979725-80979726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567673874 | chr16:80979728-80979729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191068731 | chr16:80979729-80979730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531692688 | chr16:80979731-80979732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs145200570 | chr16:80979788-80979789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571810423 | chr16:80979838-80979839 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs538740637 | chr16:80979876-80979877 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs377061812 | chr16:80979877-80979878 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs566110371 | chr16:80979903-80979904 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370478340 | chr16:80979904-80979905 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs141391133 | chr16:80979905-80979906 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73586650 | chr16:80979924-80979925 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs147652108 | chr16:80979929-80979930 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530305747 | chr16:80979948-80979949 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535473887 | chr16:80979994-80979995 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142153884 | chr16:80980038-80980039 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9652682 | chr16:80980087-80980088 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Autism | 21865298 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Obesity | 20622171 | CNVD |
Cancer | 20164920 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:80972800-80982600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr16:80974800-80986600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
3 | chr16:80979400-80979800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr16:80979800-80980400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr16:80980000-80980200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr16:80980200-80980600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr16:80980200-80981000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr16:80980400-80980600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr16:80980600-80981000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr16:80980600-80982000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr16:80981000-80981200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr16:80981000-80981800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr16:80981200-80982800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr16:80981200-80983000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr16:80981200-80983400 | Enhancers | Hela-S3 | cervix |
16 | chr16:80981400-80981800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
17 | chr16:80981400-80981800 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
18 | chr16:80981400-80982400 | Enhancers | Brain Cingulate Gyrus | brain |
19 | chr16:80981400-80982400 | Enhancers | Brain Hippocampus Middle | brain |
20 | chr16:80981400-80983000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |